DATE WEDNESDAY, APRIL
29 - 1998
SPECIAL EVENT
08:00 AM Copacabana Palace Hotel - Special Event -
ACC/ISFC/BSC
(2-4 PM
EURO AND 8-10 PM JAPAN-PROUS) (via Internet)
10:00 AM UPDATE ON CLINICAL CARDIOLOGY
CHAIRPERSON(s)
Ayrton Pires Brandão (BRAZIL)
Pravin M. Shah (U.S.A.)
PRESENTATION
Antonio J. Bayés de Luna (SPAIN)
Spencer B. King III (U.S.A.)
ARRHYTHMIAS
Gunter Breithardt (GERMANY)
HYPERTENSION
John P. Chalmers (AUSTRALIA)
ISCHEMIC HEART DISEASE
Spencer B. King, III (USA)
HEART FAILURE
Jay N. Cohn (USA)
ARRHYTHMIAS
09:00 AM Room A - Lecture
CLINICAL TRIALS - PHARMACOLOGICAL TREATMENT OF CARDIAC
ARRHYTHMIAS
09:30 AM LECTURER
Bramah B. Singh (U.S.A.)
09:30 AM Room A - Lecture
CHANGING PHYLOSOPHY IN THE TREATMENT OF CARDIAC
ARRHYTHMIAS
10:00 AM LECTURER Gunter
Breithardt (GERMANY)
10:45 AM Room D 5 - Symposium
LONG QT SYNDROME
12:15 PM
GENETIC
BACKGROUND
*
CLINICAL ASPECTS
Ronald W. F. Campbell (U.K.)
CONTROVERSIES IN PACING
INDICATIONS
Ali Oto (TURKEY)
PHARMACOLOGIC AN
NON-PHARMACOLOGICAL THERAPY
Marcelo Victor Elizari (ARGENTINA)
12:30 PM Room D 1 - Satellite Symposium
BRISTOL -MYERS SQUIBB
02:00 PM
12:30 PM Room H 1 - Satellite Symposium
PROCTER AND GAMBLE
02:00 PM ANTI-ARRHYTHMIC CLINICAL TRIALS IN THE REAL WORLD
CHAIRPERSON(s)
Craig M. Pratt (U.S.A.)
INTRODUCTION: CURRENT ISSUES
SURROUNDING CLINICAL
TRIALS
Albert Waldo (U.S.A.)
AF/F TRIALS - REVIEW OF
RECENTLY COMPLETED AND
ONGOING TRIALS
D. George Wyse (CANADA)
MORTALITY TRIALS - REVEW OF
RECENTLY COMPLETED
AND ONGOIN TRIALS
Jeremy N. Ruskin (U.S.A.)
HOW SHOULD WE MEASURE
OUTCOMES?
Craig M. Pratt (U.S.A.)
HOW DO WE IDENTIFY THE
PATIENT IN NEED OF TREATMENT.
THE CASE FOR HEART RATE
VARIABILITY
John A. Camm (U.K.)
02:15 PM Room E 2 - Symposium
NEUROCARDIOGENIC SYNCOPE - PATHOPHYSIOLOGY,
DIAGNOSIS, AND TREATMENT
03:45 PM
SYNCOPE IN
CHILDREN AND ADOLESCENTS
*
MECHANISMS AND
DIAGNOSIS
*
TILT TABLE TESTING
Andrea Natale (U.S.A.)
AMILOIDOSIS
Rodney Falk (U.S.A.)
THERAPHY
Juan Cosin Aguilar (SPAIN)
TILT TABLE TESTING
Angel Moya I Mitjans (SPAIN)
04:30 PM Main Auditorium - Symposium
ATRIAL
FIBRILLATION AND FLUTTER
05:00 PM CHAIRPERSON(S)
Graeme Sloman
(AUSTRALIA)
THROMBOEMBOLIC EVENTS:
ANALYSIS OF CLINICAL TRIALS
*
ANTICOAGULATION AND RATE CONTROL VS
SINUS RHYTHM
Philippe Coumel (FRANCE)
CATHETER ABLATION OF ATRIAL
FIBRILLATION
Andrea Natale (U.S.A.)
MAZE PROCEDURE
Eduardo Sosa (BRAZIL)
IMPLANTABLE ATRIAL
DEFIBRILLATORS
Luc Jordaens (BELGIUM)
04:30 PM Room G1- Case Presentation
ELECTROCARDIOGRAPHIC DIAGNOSIS AND INTERPRETATION
OF COMPLEX ARRHYTHMIAS
06:00 PM CHAIRPERSON(s)
Anis Rassi (BRAZIL)
*
PARTICIPANTS
Sanjay Deshpande (U.S.A.)
Marcelo Victor Elizari (ARGENTINA)
Ali Oto (TURKEY)
Yoshio Watanabe (JAPAN)
CARDIOVASCULAR
DISEASE IN THE ELDERLY
04:30 PM Room C 3 - How to treat/ Nutrition
Area
06:00 PM DYSLIPIDEMIA; CHRONIC CORONARY ARTERY DISEASE;
HEART FAILURE; HYPERTENSION
PARTICIPANTS
Gerd Assman (GERMANY)
Armênio Guimarães (BRAZIL)
Kay-Tee Khaw (U.K.)
Rodolfo Paoletti (ITALY)
CARDIOVASCULAR DISEASE IN PREGNANCY
08:30 AM Room E 2 - Symposium -
PREGNANCY-RELATED HYPERTENSION
10:00 AM CHAIRPERSON(S)
Bey Mario Lombana
(PANAMA)
HYPERTENSION IN PREGNANCY
Eduardo Salazar (MEXICO)
HYPERTENSION EMERGENCIES
Leonardo H. Reisin (ISRAEL)
AMBULATORY BLOOD PRESSURE
MONITORING IN PREGNANCY:
PREDECTIVE VALUE
Jose Luis Palma Gamiz (SPAIN)
PREVENTION OF HYPERTENSION
IN PREGNANCY: RESULTS OF
CLINICAL TRIAL
Paolo Rizzon (ITALY)
CARDIOVASCULAR NURSING
10:45 AM Room G 1 - Symposium -
Psichology/Nutrition/Techinician Areas
12:15 PM HEART FOUDANTIONS PROGRAM/ALLIED
CARDIOVASCULAR RISK REDUCTION: PRIMARY AND SECONDARY
PREVENTION
CHAIRPERSON(s)
Barbara Fletcher (U.S.A.)
NUTRITION: TRADITIONAL AND
NEW CONCEPTS
Paul K. Whelton (U.S.A.)
TOBACCO AND CORONARY DISEASE
*
PHYSICAL ACTIVITY
Robert H. Fagard (BELGIUM)
MANAGEMENT OF STRESS
*
CARDIOVASCULAR PHYSIOLOGY
MANAGEMENT OF STRESS
*
CARDIOVASCULAR PHYSIOLOGY
12:30 PM Room G 3 - Symposium
Technician Area
02:00 PM ARTIFICIAL OXYGEN CARRIERS: EVIDENCE FOR THEIR EFFICACY
IN THE MICROCIRCULATION
CHAIRPERSON(s)
Rubene Arguero Sanchez (MEXICO)
Eliete Bouskela (BRAZIL)
BLOOD VISCOSITY AND MICROVESSELL WALL GRADIENT AND THE
USE OF ARTIFICIAL BLOOD
Marcos Intaglieta (USA)
OXYGEN
CARRYING VERSUS NON CARRYING VOLUME RESSUCITATION
Konrad Messmer (GERMANY)
VESICLE
ENCAPSULATED HEMOGLOBIN AS ARTIFICIAL BLOOD CELLS
Eishun Tsuchida (JAPAN)
PROTECTION
AGAINST HEMORRAGIC SHOCK BY EXCHANGE
TRANSFUSION WITH POLYETHILENEGLYCOL-MODIFIED HEMOGLOBIN
Robert M. Winslow (U.S.A.)
CHAGAS' DISEASE
12:30 PM Room E 1 - Symposium
Pharmaco-Economy Area
02:00 PM HEART FOUNDATIONS PROGRAM
EPIDEMIOLOGY AND PUBLIC HEALTH ASPECTS OF CHAGAS' DISEASE
CHAIRPERSON(s)
Harry Acquatella (VENEZUELA)
João Carlos Pinto Dias (BRAZIL)
INTERRUPTION OF TRANSMISSION: MEDICAL AND ECONOMIC IMPACT
Alvaro Moncayo (SWITZERLAND)
COMMUNITY-BASED STUDIES: MORBIDITY AND MORTALITY PATTERNS
IN DIFFERENTS REGIONS
J. Rodrigues Coura (BRAZIL)
HOSPITAL-BASED
STUDIES: PREDICTORS OF SURVIVAL AND IMPACT
OF TREATMENT
Hernan Doval (ARGENTINA)
IMPACT
OF CHAGAS' DISEASE ON BLOOD TRANSFUSION IN ENDEMIC
AND NON-ENDEMIC COUNTRIES
Louis Vaughn Kirchhoff (USA)
EARLY
DETECTION OF MYOCARDIAL DAMAGE: IS IT COST-EFFECTIVE
AND IMPACT ON PROGNOSIS?
Hugo A. Carrasco (VENEZUELA)
02:15 PM Room D 9 - Joint Symposium - IAHF/USCAS /
ISFC/BSC
HEART FOUNDATIONS PROGRAM
03:45 PM PROGNOSIS AND MANAGEMENT OF CHAGAS' HEART DISEASE
CHAIRPERSON(s)
Rubén Storino (ARGENTINA)
NEW INSIGHTS INTO THE
PATHOGENESIS
Maria de Lourdes Higuchi (BRAZIL)
GENETIC, SEROLOGIC,
IMMUNOLOGIC, AND CLINICAL MARKERS OF
PROGNOSIS
Harry Acquatella (VENEZUELA)
ETIOLOGIC TREATMENT IN THE
ACUTE AND CHRONIC PHASES
Anis Rassi (BRAZIL)
MEDICAL AND SURGICAL
APPROACHES FOR THE TREATMENT OF
HEART FAILURE
Edimar Alcides Bocchi (BRAZIL)
EVALUATION AND TREATMENT OF
VENTRICULAR ARRHYTHMIAS
Branco Mautner (ARGENTINA)
COMMENTS
Alvaro Moncayo (SWITZERLAND
Rubén Storino (ARGENTINA)
08:30 AM Room E 1 - Plenary Session
DIAGNOSTIC AND CLINICAL ASPECTS IN CHAGAS´ HEART DISEASE
10:00 AM CHAIRPERSON(s)
Emilio Kuschnir (ARGENTINA)
José Antonio Marin Neto (BRAZIL)
EPIDEMIOLOGIC ASPECTS
Rubén Storino (ARGENTINA)
ELECTROPHYSIOLOGIC-STRUCTURAL
CORRELATIONS IN THE
CHAGASIC HEART
Eduardo Sosa (BRAZIL)
LABORATORY DIAGNOSIS OF
CHAGAS´DISEASE: WHAT IS NEW?
Louis Vaughn Kirchhoff (USA)
DOES CHAGAS´DISEASE EXIST
AS AN UNDIAGNOSED FORM OF
CARDIOMYOPATHY IN THE
UNITED STATES?
Shahbudin H. Rahimtoola (USA)
CLINICAL ASSESSMENT AND
LONG-TERM FOLLOW-UP OF THE
CHAGASIC PATIENT: ROLE
OF NON-INVASIVE TOOLS AND ENDOMYOCARDIAL
BIOPSY
Hugo A. Carrasco (VENEZUELA)
CONGESTIVE HEART FAILURE
10:45 AM Room E 3 - Controversies in Cardiology
ALL
PATIENTS WITH HEART FAILURE WITHOUT CONTRAINDICATIONS
12:15 PM SHOULD RECEIVE BETA-BLOCKER THERAPY
PARTICIPANT/Protagonist Finn Waagstein
(SWEDEN)
PARTICIPANT/Antagonist Philip A. Poole-Wilson (U.K.)
12:30 PM Room A - Symposium
Nutrition Area
02:00 PM NEW STRATEGIES IN THE TREATMENT OF HEART FAILURE
ALDOSTERONE BLOCKERS
Ariel J. Reyes (URUGUAY)
ANGIOTENSIN RECEPTOR
ANTAGONISTS
Luis Alcocer (MEXICO)
GROWTH HORMONE
Ramón Corbalán Herreros (CHILE)
ENDOTHELIN-1
RECEPTOR ANTAGONISTS
Dirk L. Brutsaert (BELGIUM)
ANTIOXIDANTS
Paolo Rizzon (ITALY)
GENE THERAPY AND CELL
TRANSPLANTATION
Robert Roberts (U.S.A.)
02:15 PM Room C 3 - Joint Symposium -
ISHR/ISFC/BSC
CELULAR ASPECTS OF HEART FAILURE
03:45 PM CHAIRPERSON(s)
Jutta Schaper (GERMANY)
SUBCELLULAR REMODELING IN
HEART FAILURE DUE TO MYOCARDIAL
INFARCTION
Naranjan S. Dhalla (CANADA)
MITOCHONDRIAL GENETIC
ABANORMALITIES IN THE FAILING HEART
N. Takeda (JAPAN)
THE LINK BETWEEN CELLULAR
EVENTS AND CLINICAL SYMPTOMATOLOGY
IN HEART FAILURE
Roberto Ferrari (ITALY)
DETERMINANTS OF HUMAN HEART
FAILURE
Norman R. Alpert (U.S.A.)
THE STRUCTURAL CORRELATE OF
DECREASED FUNCTION IN HUMAN HEART
Sava Kostin (GERMANY)
02:15 PM Room C 1 - Satellite Symposium
SMITHKLINE BEECHAM PHARMACEUTICALS & BOEHRINGER M.
03:45 PM MANAGING HEART FAILURE: TRANSLATING CLINICAL TRIALS TO CLINICAL
PRACTICE
CHAIRPERSON(s)
Michel Batlouni (BRAZIL)
Jay N. Cohn (U.S.A.)
CHAIRMAN'S INTRODUCTION
Michel Batlouni (BRAZIL)
HEART FAILURE MANAGEMENT:
REDEFINING THERAPEUTIC NEEDS
Norman Sharpe (NEW ZEALAND)
RECENT TRIALS DATA: PAVING
THE WAY FOR CLINICIANS
Jay N. Cohn (U.S.A.)
GUIDELINE: THE BRIDGE
BETWEEN CLINICAL TRIALS AND PRACTICE
Willem J. Remme (THE NETHERLANDS)
STRATEGIES FOR SUCCESS:
ACHIEVING MAXIMUM PATIENT BENEFIT
John G. F. Cleland (U.K.)
02:15 PM Room E 3 - Case Presentation
CASE
PRESENTATION IN HEART FAILURE
03:45 PM PARTICIPANTS
William J. McKenna (U.K.)
Willem J. Remme (THE NETHERLANDS)
David H. Spodick (U.S.A.)
Finn Waagstein (SWEDEN)
04:30 PM Room E 1 - Meet the Experts
Pharmaco-Economy Area
06:00 PM HEART FAILURE CLINICS - A COST-EFFECTIVE STRATEGY FOR
QUALITY CARE
PARTICIPANTS
Dirk L. Brutsaert (BELGIUM)
John G.F. Cleland (U.K.)
Thomas Lee (U.S.A.)
Norman Sharpe (NEW ZEALAND)
04:30 PM Room F 1 - Plenary Session
STATE
OF THE ART IN HEART FAILURE THERAPY
06:00 PM CHAIRPERSON(s)
Elliot Rapaport (U.S.A.)
PREVENTION OF HEART FAILURE
Norman Sharpe (NEW ZEALAND)
TREATMENT OF ASYMPTOMATIC
LEFT VENTRICULAR DYSFUNCTION
Wilhelm J. Rutishauser (SWITZERLAND)
TREATMENT OF DIASTOLIC
DYSFUNCTION
William J. McKenna (U.K.)
TREATMENT OF HEART FAILURE
DUE TO SYSTOLIC DYSFUNCTION
Jay N. Cohn (U.S.A.)
MANAGEMENT OF END-STAGE
HEART FAILURE
J. Malcom O. Arnold (CANADA)
04:30 PM Room G 8 - Lecture
MOLECULAR BIOLOGY OF HEART FAILURE
05:00 PM LECTURER
Ketty Schwartz (FRANCE)
05:00 PM Room G 8 - Lecture
ENDOTHELIAL DYSFUNCTION IN HEART FAILURE
05:30 PM LECTURER
Markku S. Nieminen (FINLAND)
CORONARY CIRCULATION
08:30 AM Room D 9 - Lecture
Nutrition Area
09:15 AM THE OXIDATIVE THEORY OF ATHEROSCLEROSIS
LECTURER
Robert Wayne Alexander (USA)
08:30 AM Room C 3 - Symposium
NEW
ISCHEMIC SYNDROMES
10:00 AM CHAIRPERSON(s)
Richard L. Popp (U.S.A.)
MYOCARDIAL PROTECTION WITH
PRECONDITIONING
Juan Carlos Kaski (U.K.)
DELAYED PRECONDITINING
PHENOMENON - A SECOND WINDOW
OF PROTECTION
Lionel H. Opie (SOUTH AFRICA)
HOW DOES HIBERNATION
DEVELOP: RESULTS FROM EXPERIMENTAL
MODELS
Roberto Ferrari (ITALY)
HYBERNATION IN HEART FAILURE
Shahbudin H. Rahimtoola (USA)
08:30 AM Room E 3 - Meet the Experts
ASSESSMENT OF MYOCARDIAL VIABILITY
10:00 AM CHAIRPERSON(s)
Enrique Asin Cardiel (SPAIN)
Robert Bonow (U.S.A.)
PARTICIPANTS
Vasken Dilsizian (U.S.A.)
Ami Iskandrian (U..S.A)
Eugênio Picano (ITALY)
09:15 AM Room D 9 - Lecture
PLAQUE RUPTURE: THE TRIGGER OF ACUTE ISCHEMIC SYNDROMES
10:00 AM CHAIPERSON(S)
Antonio Carlos Palandri Chagas (BRAZIL)
LECTURER
Peter Ganz (U.S.A.)
10:45 AM Room A - Joint Symposium - IASC / ISFC
/BSC
ACUTE MYOCARDIAL INFARCTION - CONCEPTS
12:15 PM CHAIRPERSON(s)
Edgardo
Escobar (CHILE)
Wolfgang Kubler (GERMANY)
RISK STRATIFICATION IN THE
CORONARY CARE UNIT
Robert O'Rourke (USA)
MARKERS OF LEUKOCYTE
ACTIVATION IN HUMAN MYOCARDIAL
ISCHEMIA
Attilio Maseri (ITALY)
PRIMARY ANGIOPLASTY
Costantino Costantini (BRAZIL)
STENTING
Antonio Colombo (ITALY)
VENTRICULAR REMODELING
Edgardo Escobar (CHILE)
10:45 AM Room H 1 - Plenary Session
ACUTE MYOCARDIAL INFARCTION - TREATMENT
12:15 PM CHAIRPERSON(s)
James S. Forrester (U.S.A.)
Liliana Grinfeld (ARGENTINA)
CONVENTIONAL TREATMENT
Lars E. Ryden (SWEDEN)
THROMBOLYTIC TREATMENT
W. Douglas Weaver (U.S.A.)
RISK STRATIFICATION
Thomas J. Ryan (U.S.A.)
CORONARY ANGIOPLASTY
José Eduardo Moraes Rego e Sousa (BRAZIL)
SURGICAL TREATMENT
Delos M. Cosgrove (U.S.A.)
02:15 PM Main Auditorium - Lecture
NITRIC OXIDE: MORE THAN AN ENDOTHELIUM DERIVED RELAXING FACTOR
03:00 PM CHAIRPERSON(s)
Francisco Laurindo (BRAZIL)
LECTURER
Salvador Moncada (UK)
02:15 PM Room A - Clinical Decision Making
2
CASES, 5 PARTICIPANTS
03:45 PM CHAIRPERSON(s)
Protasio Lemos Da Luz (BRAZIL)
Robert O’Rourke (U.S.A.)
PARTICIPANTS
Alexander Battler (ISRAEL)
Rene G. Favaloro (ARGENTINA)
Eulo Lupi Herrera (MEXICO)
Wilhelm J. Rutishauser (SWITZERLAND)
03:00 PM Main Auditorium - Lecture
INFLAMMATION AND ATHEROSCLEROSIS
03:45 PM LECTURER
Peter Libby (USA)
04:30 PM Room A - Lecture
REGRESSION TRIALS IN ATHEROSCLEROSIS: PRACTICAL IMPLICATIONS
OF CONTROLLED STUDIES
05:00 PM LECTURER
Terje R. Pedersen (NORWAY)
04:30 PM Room H 1 - Joint Symposium -
INCOR/ISFC/BSC
Nutrition Area
06:00 PM PATHOPHYSIOLOGY AND TREATMENT OF CORONARY
DISEASE
CHAIRPERSON(s)
Adib Domingos Jatene (BRAZIL)
José Antonio Franchini Ramires (BRAZIL)
NATURAL HISTORY OF CAD: SLOW
PROGRESSION PLAQUE
INSTABILIZATION
Peter Libby (U.S.A.)
RECOGNITION OF THE ISCHEMIC
MYOCARDIUM - A CRITIQUE OF
TECHNIQUES
Mario S. Verani (U.S.A.)
CLINICAL APLICATION OF
REGRESSION STUDIES. WHAT SHOULD
THE CLINICIAN DO?
Luiz Antonio Machado Cesar (BRAZIL)
ANTI-OXIDANTS, WINE
AND VITAMINS. THEORIES AND FACTS
Protasio Lemos Da Luz (BRAZIL)
SURGICAL TREATMENT OF
ISCHEMIC LV DYSFUNCTION
Adib Domingos Jatene (BRAZIL)
DRUG THERAPY
12:30 PM Room C 1 - Satellite Symposium
NOVARTIS PHARMA AG
02:00 PM EXPANDING THE BENEFITS OF VALSARTAN, A NOVEL
ANGIOTENSIN II ANTAGONIST, TODAY AND TOMORROW
CHAIRPERSON(s)
Jay N. Cohn (U.S.A.)
G. T. McInnes
CLINICAL ADVANTAGES OF
VALSARTAN
G. T. McInnes
CARDIOPROTECTIVE EFFECTS OF
VALSARTAN: REGRESSION OF LVH
P. Thürmann
IMPROVING OUTCOMES IN CHF:
THE VAL-HEFT TRIAL
Jay N. Cohn (USA)
LONG-TERM EFFECTS OF
VALSARTAN ON CARDIOVASCULAR
MORBIDITY &
MORTALITY: THE VALUE TRIAL IN HYPERTENSION
Stevo Julius (U.S.A.)
DISCUSSION
All Participants
12:30 PM Room C 3 - Satellite Symposium
Pharmaco-Economy Area
02:00 PM BOEHRINGER MANNHEIM
DIURETICS IN THE MANAGEMENT OF CARDIOVASCULAR DISEASE
CHAIRPERSON(s)
Mario Fernando de Camargo Maranhão (BRAZIL)
Stanley H. Taylor (U.K.)
CHAIRMAN'S INTRODUCTION
Stanley H. Taylor (U.K.)
DIURETICS AS FIRST-LINE
THERAPY IN HYPERTENSION - JNC
VI GUIDELINES
Norman Kaplan (U.S.A.)
TREATMENT OF HYPERTENSION
WITH LOW DOSE DIURETICS
Vasillos Papademetriou (U.S.A.)
PREVENTION OF CHF WITH
DIURETICS AND B-BLOCKERS-EXPERIENCE
FORM THE PRIMARY
PREVENTION TRIALS
D. Haller (GERMANY)
ESSENTIAL FEATURES OF
DIURETIC THERAPY IN HEART FAILURE:
PREDICTABILITY AND
CONTROL
John Nicklas (U.S.A.)
CLINICAL OUTCOMES AND
COST-EFFECTIVENESS OF TORASEMIDE IN CHF
John G. F. Cleland (U.K.)
CHAIRMAN'S SUMMARY
Mario Fernando de Camargo Maranhão (BRAZIL)
12:30 PM Room F 1 - Satellite Symposium
SEARLE INTERNATIONAL
02:00 PM CHRONOBIOLOGY IN CARDIOVASCULAR DISEASE
CHAIRPERSON(s)
Jose Antonio Franchini Ramires (BRAZIL)
William B. White (U.S.A.)
INTRODUCTORY REMARKS
William B. White (U.S.A.)
Jose Antonio Franchini Ramires (BRAZIL)
CIRCADIAN VARIATION IN
CARDIOVASCULAR DISEASE
William B. White (U.S.A.)
MORNING EVENTS AND OTHER
TRIGGERS OF CARDIOVASCULAR
DISEASE
James E. Muller (U.S.A.)
CHRONOTHERAPEUTICS:
APPLICATIONS IN CARDIOVASCULAR AND
OTHER DISEASES
William Elliott (U.S.A.)
REVIEW OF ONGOING CLINICAL
OUTCOMES AND STUDIES OF
CALCIUM ANTAGONISTS
Décio Mion Junior (BRAZIL)
04:30 PM Room C 1 - Satellite Symposium
ELI LILLY & COMPANY
06:00 PM IMPACT OF SYMPATHETIC TONE ON THE PATHOPHYSIOLOGY OF
CARDIOVASCULAR DISEASE
CHAIRPERSON(s)
Emílio Antonio Francischetti (BRAZIL)
Michael A. Weber (U.S.A.)
THE RATIONALE FOR
SYMPATHETIC MODULATION IN THE TREATMENT OF
HYPERTENSION AND
CARDIOVASCULAR RISK FACTORS
Michael A. Weber (U.S.A.)
SYMPATHETIC OVER-ACTIVITY
AND INSULIN RESISTANCE
Stevo Julius (U.S.A.)
PHARMACOLOGY OF IMIDAZOLINE
RECEPTOR AGONIST
Paul Ernsberger (U.S.A.)
THE SYMPATHETIC NERVOUS
SYSTEM AND HEART FAILURE:
POTENTIAL THERAPEUTIC
TARGETS IN THE TREATMENT OF THE
METABOLIC SYNDROME
Claude Benedict (U.S.A.)
QUESTION AND ANSWER SESSION
All Participants
ECHOCARDIOGRAPHY
08:30 AM Room F 1 - Lecture
MYOCARDIAL VIABILITY IN : ITS IMPORTANCE AND APPROACHES
FOR ITS ASSESSMENT
09:00 AM LECTURER
James Willerson (U.S.A.)
09:00 AM Room F 1 - Lecture
THREE
AND FOUR-DIMENSION ECHOCARDIOGRAPHY
09:30 AM CHAIRPERSON(S)
Fernando Santana Machado (BRAZIL)
LECTURER
Navin C. Nanda (USA)
09:30 AM Room F 1 - Lecture /
RISK STRATIFICATION IN CORONARY ARTERY DISEASE: NON-INVASIVE
10:00 AM IMAGING APPROACHES FOR THE TWENTY FIRST CENTURY
CHAIRPERSON(S)
Cantídio Drummond Neto (BRAZIL
LECTURER
Mario S. Verani (U.S.A.)
EPIDEMIOLOGY & PREVENTION
08:30 AM Room C 1 - Joint Symposium -
AHA/ISFC/BSC
Nursing Area
10:00 AM HEART FOUNDATIONS PROGRAM
SECONDARY PREVENTION ON
CARDIOVASCULAR DISEASE
CHAIRPERSON(s)
Rodman Starke (U.S.A.)
Gilles Richard Dagenais (CANADA)
SCOPE OF THE SECONDARY
PREVENTION PROBLEM
Sidney C. Smith Jr. (U.S.A.)
COMPLIANCE WITH
RECOMMENDATION
Martha N. Hill (U.S.A.)
ASIAN PACIFIC SURVEY OF
SECONDARY PREVENTION OF CORONARY
HEART DISEASE
David Wood (U.K.)
EXERCISES TESTING, CARDIAC
REHABILITATION AND EXERCISE
CARDIOLOGY
02:15 PM Room G 8 - Symposium
Technician Area
03:45 PM THE ATHLETE´S HEART
CHAIRPERSON(s)
Eduardo H. De Rose (BRAZIL)
CARDIOVASCULAR ADAPTATIONS
TO EXERCISE TRAINING
L. Howard Hartley (U.S.A.)
ECHOCARDIOGRAPHIC FINDINGS
Richard L. Popp (U.S.A.)
ELECTROPHYSIOLOGICAL
FINDINGS
Gary J. Balady (USA)
SUDDEN CARDIAC DEATH
Barry Maron (USA)
LVH: PHYSIOLOGICAL AND
PATHOLOGICAL
Maria Teresa Subirana (SPAIN)
GROWN-UP CONGENITAL HEART DISEASE
09:30 AM Room D 5 - Lecture
DOES
GENDER MATTER IN GROWN-UP CONGENITAL HEART DISEASE
10:00 AM LECTURER
Jane Somerville (UK)
02:15 PM Room E 1 - Symposium
LATE
OUTCOMES OF REPAIR OF CONGENITAL HEART DISEASE
03:45 PM CHAIRPERSON(s)
Milton Ary Meier (BRAZIL)
Alfredo Vizcaino-Alarcon (MEXICO)
TRANSPOSITION OF THE GREAT
ARTERIES - SWITCH
Adib Domingos Jatene (BRAZIL)
PULMONARY ATRESIA WITH
INTACT SEPTUM
Robert Freedom (CANADA)
ATRIOVENTRICULAR CANAL
Fause Attie (MEXICO)
COMPLEX FALLOT'S TETRALOGY
*
RIGHT VENTRICULAR OUTFLOW
TRACT RECONSTRUCTION WITH
VALVELESS CONDUITS
Miguel Barbero (BRAZIL)
HYPERTENSION
08:30 AM Main Auditorium - Lecture
HYPERTENSION IN THE ELDERLY: IS IT DIFFERENT?
09:00 AM LECTURER
Norman Kaplan (USA)
09:00 AM Main Auditorium - Lecture
ANGIOTENSIN CONVERTING ENZYME: FROM DISCOVERY TO
CLINICAL APPLICATION
09:30 AM LECTURER
Sergio Henrique Ferreira (BRAZIL)
09:30 AM Main Auditorium - Lecture
NEW
ADVANCES IN HYPERTENSION: DIAGNOSTIC AND THERAPEUTIC STRATEGIES
10:00 AM LECTURER
Giuseppe Mancia (ITALY)
10:45 AM Room C 1 - Satellite Symposium
MERCK SHARP & DOHME
12:15 PM HYPERTENSION: ITS PREVALENCE, RISKS & THERAPIES
CHAIRPERSON(s)
Michel Batlouni (BRAZIL)
RAAS: 100 YEARS
Michel Batlouni (BRAZIL)
HYPERTENSION REPORT
CARD: EPIDEMIOLOGICAL ASPECTS AND
THEIR CONSEQUENCES
Décio Mion Junior (BRAZIL)
24-HOUR BLOOD PRESSURE
CONTROL AND PATIENT COMPLIANCE
Haralambos P. Gavras (U.S.A.)
CARDIOPROTECTION OF ACE
INHIBITORS: PRACTICAL IMPLICATIONS
John Farmer (U.S.A.)
PANEL DISCUSSION
All Participants
10:45 AM Room F 1- Symposium
LEFT
VENTRICULAR HYPERTROPHY AND HYPERTENSION: NEW INSIGHTS
12:15 PM AS A RISK FACTOR
William B. Kannel (U.S.A.)
PATHOGENESIS
Edward D. Frohlich (U.S.A.)
NEURO-HUMORAL CONTROL
Stevo Julius (U.S.A.)
TREATMENT AND REGRESSION
Björn Dahlöf (SWEDEN)
MOLECULAR AND CELULAR BASIS
*
12:30 PM Room D 9 - Satellite Symposium
HOECHST- MARION ROUSSEL
02:00 PM HYPERTENSION TO HEART FAILURE AND BEYOND...
CHAIRPERSON(s)
Stephen G. Ball (U.K.)
Antonio Carlos Pereira Barreto (BRAZIL)
INTRODUCTION
Antonio Carlos Pereira Barreto (BRAZIL)
HYPERTENSION TO HEART
FAILURE - THE GLOBAL CHALLENGE
W. J. Louis (AUSTRALIA)
SHORT OR LONG TERM ACE
INHIBITOR THERAPY FOR HEART FAILURE
POST MI PATIENTS
Stephen G. Ball (U.K.)
ANTIISCHEMIC PROPERTIES OF
ACE INHIBITORS
L. Erhardt (SWEDEN)
THE ROLE OF ACE INHIBITORS
IN THE PREVENTION AND TREATMENT
OF ATHEROSCLEROSIS
Leopoldo Soares Piegas (BRAZIL)
PANEL DISCUSSION
All Participants
CONCLUSION
Stephen G. Ball (U.K.)
02:15 PM Room G 5 - Plenary Session
STATE OF THE ART OF ANTIHYPERTENSIVE THERAPY
03:45 PM
DIURETICS
Ariel J. Reyes (URUGUAY)
BETA-BLOCKERS
Luis Alcocer (MEXICO)
ACE INHIBITORS
Colin Johnston (AUSTRALIA)
CALCIUM ANTAGONIST
Peter S. Sever (UK)
ANGIOTENSIN II ANTAGONIST
Haralambos P. Gavras (U.S.A.)
COMBINATION THERAPY
John P. Chalmers (AUSTRALIA)
04:30 PM Room G 5 - Symposium
TREATMENT OF HYPERTENSION IN SPECIAL GROUPS
06:00 PM
CHILHOOD
Ayrton Pires Brandão (BRAZIL)
DIABETES
B. Ferris (U.K.)
PREGNANCY
Suzanne Oparil (U.S.A.)
ORGAN TRANSPLANTATION
Hector O. Ventura (U.S.A.)
CORONARY HEART
DISEASE
Stanley H. Taylor (U.K.)
ELDERLY
John P. Chalmers (AUSTRALIA)
INTERVENTIONAL CARDIOLOGY
02:15 PM Room G 1 - Controversies in Cardiology
LEFT
ANTERIOR DESCENDING PROXIMAL LESIONS: STENTS VS
MINIMMALLY INVASIVE SURGERY
03:45 PM CHAIRPERSON(s)
Luis Moya Jimenez (COLOMBIA)
PARTICIPANT/Protagonist *
PARTICIPANT/Antagonist Delos M. Cosgrove
(USA)
MYOCARDIAL & PERICARDIAL DISEASES
10:45 AM Room G 5 - Symposium
HYPERTROPHIC CARDIOMYOPATHY IN THE FRONTEIR OF
THE MILLENIUM
12:15 PM CHAIRPERSON(s)
John E. Goodwin
Miran F. Kenda (SLOVENIA)
UNRAVELING THE GENETICS
Ketty Schwartz (FRANCE)
PRESENT AND FUTURE THERAPY
Robert Roberts (USA)
NEW AND OLD
MODALITIES OF TREATMENT: ROLE OF DRUGS,
PACING, ABLATION, AND
SURGERY
E. Douglas Wigle (CANADA)
CURRENT APPROACHES TO
CLINICAL DIAGNOSIS
Barry Maron (U.S.A.)
05:30 PM Room G 8 - Lecture
NEW
ASPECTS OF PATHOGENESIS OF HEART FAILURE: HEPATITIS-C
06:00 PM VIRUS INFECTION IN MYOCARDITIS AND CARDIOMYOPATHY
LECTURER
Shigetake Sasayama (JAPAN)
PEDIATRIC
CARDIOLOGY
08:30 AM Room D 5 - Lecture
NEW
INSIGHTS INTO THE ETIOLOGY AND THE PATHOGENESIS OF
CONGENITAL HEART DISEASE
09:00 AM LECTURER
Anton E. Becker (THE NETHERLANDS)
09:00 AM Room D 5 - Lecture
PEDIATRIC CARDIOLOGY IN THE ERA OF EVIDENCE-BASED MEDICINE
09:30 AM LECTURER
Robert Freedom (CANADA)
10:45 AM Room E 2 - Symposium
TRANSPOSITION OF THE GREAT ARTERIES
12:15 PM
NATURAL HISTORY
Joseph K. Perloff (USA)
COMPLEX
TRANSPOSITION
*
MUSTARD-SENNING´S PROCEDURE - LONG TERM RESULTS
Robert Freedom (CANADA)
JATENE´S
PROCEDURE - LONG TERM RESULTS
Adib Domingos Jatene (BRAZIL)
12:30 PM Room G 5 - Symposium
Psychology/Nutrition/Technician Areas
02:00 PM HEART FOUNDATIONS PROGRAM
PRIMARY PREVENTION OF
CARDIOVASCULAR DISEASE IN CHILDREN
CHAIRPERSON(S)
James H. Moller (U.S.A.)
OVERWEIGHT
Susana Sans (SPAIN)
DYSLIPIDEMIAS
Terje R. Pedersen (NORWAY)
HIGH BLOOD PRESSURE
Darwin R. Labarthe (U.S.A.)
SMOKING
Ximena Berrios (CHILE)
04:30 PM Room E 3 -Lecture
FETAL CARDIOLOGY - STATE OF THE ART
06:00 PM LECTURER
Paulo Zielinsky
(BRAZIL)
PULMONARY CIRCULATION
04:30 PM Room E 2 - Plenary Session
Technician Area
06:00 PM SPECIAL ISSUES IN PULMONARY CIRCULATION
CHAIRPERSON(s)
Peter Harris (U.K.)
Mario Rigatto (BRAZIL)
OXYGEN SENSING AND THE
CONTROL OF THE PULMONARY
CIRCULATION
Stuart Rich (U.S.A.)
PHARMACOLOGICAL MANAGEMENT
OF PRIMARY PULMONARY
HYPERTENSION
Peter Harris (U.K.)
HIGH ALTITUDE PULMONARY
HYPERTENSION: OLD FACTS AND
EMERGING CONCEPTS
Dante Peñaloza (PERU)
MANAGEMENT OF THROMBOEMBOLIC
PULMONARY HYPERTENSION
Stuart W. Jamieson (USA)
PULMONARY HYPERTENSION IN
THE NEWBORN
Sheila G. Haworth (UK)
PATHOPHYSIOLOGY AND
MANAGEMENT OF PULMONARY HYPERTENSION
IN CHILDREN WITH
CONGENITALHEART DISEASE
Fause Attie (MEXICO)
THROMBOSIS & PLATELETS
02:15 PM Room F 1 - Satellite Symposium
SANOFI PHARMA & BRISTOL MYERS SQUIBB
03:45 PM CLOPIDOGREL, AN ADVANCED ADP RECEPTOR ANTAGONIST, FOR
PATIENTS AT RISK OF ATHEROTHROMBOSIS
CHAIRPERSON(s)
James H. Chesebro (USA)
José Carlos Nicolau (BRAZIL)
PRECLINICAL
DATA ON CLOPIDOGREL
Lawrence A. Harker (U.S.A.)
MECHANISMS OF ACTION OF CLOPIDOGREL
Ludovic Drouet (FRANCE)
CLINICAL MANIFESTATIONS OF ATHEROTHROMBOSIS
Michael H. Criqui (U.S.A.)
ATHEROTHROMBOSIS TREATMENT: PERSPECTIVE FROM THE
NEUROLOGIST
José Biller (U.S.A.)
PERSPECTIVE FROM THE VASCULAR SPECIALIST
M. Craeger (U.S.A.)
IMPORTANCE OF MI PREVENTION IN THE CAPRIE POPULATION
James H. Chesebro (U.S.A.)
02:15 PM Room H 1 - Satellite Symposium
BOEHRINGER
INGELHEIM GmbH
03:45 PM ANTIPLATELET DRUGS IN SECONDARY PREVENTION:
ARE THEY
DIFFERENTLY EFFECTIVE IN PATIENTS AFTER STROKE AND
AFTER MI?
CHAIRPERSON(S)
Denilson Campos de Albuquerque (BRAZIL)
Charles Forbes (U.K.)
ANTIPLATELET
DRUGS: SINGLE DRUG OR COMBINATION TREATMENT
Arnold G. Herman (Belgium)
RECENTLY
FINISHED TRIALS: ESP II, CAPRIE, IST, CAST
Charles Forbes (U.K.)
ASA
AND DIPYRIDAMOLE IN SECONDARY PREVENTION OF STROKE,
UPDATED META-ANALYSIS
Jan G.P. Tijssen (THE NETHERLANDS)
02:15 PM Room G 9 - Meet the Experts
ASPIRIN FOR PREVENTION OF CARDIOVASCULAR DISEASE
03:45 PM PARTICIPANTS
James H. Chesebro (U.S.A.)
Juan Cosin Aguilar (SPAIN)
Mario R. Garcia Palmieri (PUERTO RICO)
Stanley H. Taylor (U.K.)
VALVULAR HEART DISEASE
08:30 AM Room H 1 - Lecture
BALOON VALVULOPLASTY: EARLY AND LATE RESULTS
09:00 AM LECTURER
Igor Palacios (U.S.A.)
09:00 AM Room H 1 - Lecture
SURGICAL APPROACH TO VALVULAR HEART DISEASE
09:30 AM LECTURER
Delos M. Cosgrove (USA)
10:45 AM Room C 3 - Plenary Session
NATURAL
HISTORY AND PROGNOSIS OF AORTIC AND MITRAL
VALVE DISEASE
12:15 PM
MITRAL VALVE PROLAPSE
Edgardo Escobar (CHILE)
RHEUMATIC
MITRAL VALVE DISEASE
Edward Kaplan (U.S.A.)
CALCIFIC
AORTIC STENOSIS
*
DEGENERATIVE AORTIC INSUFICIENCY
Shahbudin H. Rahimtoola (U.S.A.)
RHEUMATIC
AORTIC VALVE DISEASE
Robert Bonow (U.S.A.)
02:15 PM Room D 5 - Symposium
SPECIAL
TOPICS IN VALVULAR HEART DISEASE
03:45 PM CHAIRPERSON(s)
Igor Riecansky (SLOVAK
REPUBLIC)
NATURAL HISTORY OF MITRAL AND AORTIC VALVE DISEASE
Abdul Jamil Tajik (U.S.A.)
PERCUTANEOUS MITRAL VALVULOPLASTY IN JUVENILE
MITRAL STENOSIS
Manotosh Panja (INDIA)
MITRAL VALVE REPAIR IN ACUTE RHEUMATIC CARDITIS
Pravin Manga (SOUTH AFRICA)
MITRAL COMISSUROTOMY WITH PERCUTANEOUS METALIC DEVICE
Paulo Rocha (FRANCE)
STATE OF THE
ART VALVE PROSTHESIS
*
|
